Laporan Laba Rugi (TTM)
Laporan Laba Rugi Oncopeptides AB (publ) - Equity Right menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19 | 86 | 140 | 118 | 99 | 41 | -14 | 8 | 9 | 27 | 30 | 35 | 39 | 21 | 27 | 32 | 40 | 51 |
| Change (%) | 342.93 | 63.31 | -15.51 | -16.36 | -58.24 | -133.68 | -160.04 | 13.45 | 181.46 | 14.10 | 15.69 | 11.21 | -45.44 | 26.68 | 16.91 | 25.89 | 27.68 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 0 | 3 | 35 | 53 | 53 | 50 | 18 | 0 | 0 | 0 | -2 | -1 | -1 | 0 | 3 | 3 | 2 | 2 |
| Change (%) | 860.37 | 1,002.95 | 52.90 | -0.62 | -5.35 | -63.22 | -99.97 | 183.33 | 147.06 | -4,514.29 | -41.80 | -25.58 | -114.82 | 2,183.19 | -1.99 | -13.97 | -24.09 | |
| % of Revenue | 1.69 | 3.67 | 24.82 | 44.91 | 53.36 | 120.94 | -132.07 | 0.07 | 0.18 | 0.16 | -6.09 | -3.06 | -2.05 | 0.56 | 10.04 | 8.41 | 5.75 | 3.42 |
| Gross Operating Profit | 19 | 83 | 105 | 65 | 46 | -9 | -32 | 8 | 9 | 27 | 32 | 36 | 40 | 21 | 24 | 29 | 38 | 49 |
| Change (%) | 334.01 | 27.47 | -38.08 | -29.19 | -118.75 | 273.24 | -125.85 | 13.33 | 181.53 | 21.24 | 12.39 | 10.12 | -46.84 | 14.61 | 19.02 | 29.56 | 30.83 | |
| % of Revenue | 98.31 | 96.33 | 75.18 | 55.09 | 46.64 | -20.94 | 232.07 | 99.93 | 99.82 | 99.84 | 106.09 | 103.06 | 102.05 | 99.44 | 89.96 | 91.59 | 94.25 | 96.58 |
| SG&A | 788 | 889 | 907 | 874 | 681 | 464 | 304 | 142 | 154 | 178 | 178 | 188 | 189 | 190 | 197 | 197 | 197 | 200 |
| Change (%) | 12.78 | 1.97 | -3.62 | -22.04 | -31.86 | -34.62 | -53.15 | 8.45 | 15.18 | 0.21 | 5.89 | 0.21 | 0.54 | 3.80 | 0.09 | -0.18 | 1.32 | |
| % of Revenue | 4,073.30 | 1,037.17 | 647.58 | 738.67 | 688.53 | 1,123.50 | -2,181.22 | 1,701.92 | 1,626.84 | 665.76 | 584.67 | 535.15 | 482.21 | 888.63 | 728.09 | 623.36 | 494.24 | 392.24 |
| R&D | 831 | 771 | 727 | 680 | 567 | 444 | 345 | 218 | 182 | 175 | 131 | 107 | 105 | 95 | 111 | 121 | 122 | 115 |
| Change (%) | -7.28 | -5.66 | -6.48 | -16.58 | -21.67 | -22.40 | -36.87 | -16.43 | -3.78 | -25.13 | -18.39 | -1.70 | -9.20 | 16.41 | 9.07 | 0.40 | -5.60 | |
| % of Revenue | 4,294.48 | 898.98 | 519.30 | 574.77 | 573.30 | 1,075.34 | -2,477.82 | 2,605.11 | 1,918.94 | 656.03 | 430.44 | 303.66 | 268.40 | 446.67 | 410.43 | 382.92 | 305.37 | 225.78 |
| OpEx | 1,590 | 1,663 | 1,637 | 1,611 | 1,343 | 959 | 696 | 355 | 330 | 349 | 301 | 288 | 285 | 278 | 308 | 314 | 317 | 311 |
| Change (%) | 4.58 | -1.57 | -1.59 | -16.63 | -28.56 | -27.43 | -48.97 | -7.04 | 5.61 | -13.70 | -4.33 | -1.09 | -2.45 | 10.67 | 2.17 | 0.75 | -1.89 | |
| % of Revenue | 8,216.04 | 1,939.83 | 1,169.11 | 1,361.64 | 1,357.31 | 2,322.05 | -5,003.67 | 4,252.44 | 3,484.44 | 1,307.48 | 988.87 | 817.74 | 727.32 | 1,300.48 | 1,136.11 | 992.91 | 794.63 | 610.60 |
| Operating Income | -1,571 | -1,577 | -1,497 | -1,492 | -1,244 | -918 | -710 | -347 | -321 | -322 | -271 | -253 | -246 | -257 | -280 | -283 | -277 | -260 |
| Change (%) | 0.41 | -5.10 | -0.29 | -16.65 | -26.19 | -22.65 | -51.15 | -7.53 | 0.42 | -16.00 | -6.58 | -2.80 | 4.40 | 9.34 | 0.75 | -2.06 | -6.15 | |
| % of Revenue | -8,116.04 | -1,839.83 | -1,069.11 | -1,261.64 | -1,257.31 | -2,222.05 | 5,103.67 | -4,152.44 | -3,384.44 | -1,207.48 | -888.87 | -717.74 | -627.32 | -1,200.48 | -1,036.11 | -892.91 | -694.63 | -510.60 |
| Interest Expense | -2 | -2 | -1 | -1 | -0 | -0 | -1 | -1 | -1 | -1 | -6 | -8 | -8 | -7 | -13 | -11 | -18 | |
| Change (%) | 26.62 | -32.10 | -29.09 | -54.96 | 492.62 | -0.00 | -0.00 | -0.00 | 555.15 | 36.13 | -0.37 | -8.31 | 75.95 | -10.29 | 58.08 | |||
| % of Revenue | -8.03 | -2.30 | -0.95 | -0.80 | -0.43 | 1.07 | -10.57 | -9.32 | -3.31 | -2.90 | -16.43 | -20.11 | -36.72 | -26.57 | -40.00 | -28.50 | -35.29 | |
| Net Income | -1,532 | -1,155 | -1,549 | -1,430 | -1,294 | -1,330 | -641 | -338 | -310 | -307 | -259 | -249 | -246 | -263 | -282 | -285 | -278 | -267 |
| Change (%) | -24.60 | 34.13 | -7.68 | -9.51 | 2.76 | -51.81 | -47.26 | -8.16 | -1.13 | -15.61 | -3.82 | -1.33 | 6.88 | 7.50 | 0.78 | -2.47 | -3.74 | |
| % of Revenue | -7,915.41 | -1,347.39 | -1,106.60 | -1,209.11 | -1,308.11 | -3,218.74 | 4,605.41 | -4,044.90 | -3,274.49 | -1,150.28 | -850.76 | -707.30 | -627.53 | -1,229.36 | -1,043.15 | -899.29 | -696.66 | -525.22 |
Source: Capital IQ
